Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2. (Q34060758)

30 July 2017

1 reference

title

Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2. (English)

1 reference

30 July 2017

Holst JJ

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

93

1 reference

30 July 2017

issue

1-3

1 reference

30 July 2017

page(s)

45-51

1 reference

Relationship of glicentin to proglucagon and glucagon in the porcine pancreas

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Hamster preproglucagon contains the sequence of glucagon and two related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Exon duplication and divergence in the human preproglucagon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Characterization of Glucagon-like Immunoreactivity (GLI)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Radioimmunological determination of pancreatic and gut glucagon in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Gut hormones in adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

The amino acid sequence of porcine glicentin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Evidence that glicentin contains the entire sequence of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glicentin inhibits gastric acid secretion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Circulating glucagon after total pancreatectomy in man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Absence of islet alpha cell function in pancreatectomized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Stimulation of truncated glucagon-like peptide-1 release from the isolated perfused canine ileum by glucose absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

The role of the gut in regulating food intake in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Ileal release of glucagon-like peptide-1 (GLP-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Central glucagon-like peptide-I in the control of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Structure, measurement, and secretion of human glucagon-like peptide-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

New frontiers in the biology of GLP-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2800%2900185-3

7 January 2021

10.1016/S0167-0115(00)00185-3

Identifiers

DOI

1 reference

30 July 2017

1 reference